Exploring the biological potential of the brominated indenoindole MC11 and its interaction with protein kinase CK2
Authors:
- Christelle MarminonCMChristelle Marminon
- Christian WernerCWChristian Werner
- Alexander GastAGAlexander Gast
- Lars HerfindalLHLars Herfindal
- Johana CharlesJCJohana Charles
- Dirk LindenblattDLDirk Lindenblatt
- Angélique MularoniAMAngélique Mularoni
- Stein Ove DøskelandSDStein Ove Døskeland
- Joachim JoseJoachim Jose
- Karsten NiefindKarsten Niefind
- Marc Le BorgneMarc Le Borgne
Open Access
- 1 March 2025
- journal article
- research article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 406 (3-4) , 125-138
Abstract
Protein kinase CK2 is a promising therapeutic target, especially in oncology. Over the years, various inhibitors have been developed, with polyhalogenated scaffolds emerging as a particularly effective class. Halogens like bromine and chlorine enhance inhibitor stability by forming additional interactions within the ATP pocket. Among halogenated scaffolds, benzotriazole and benzimidazole have led to potent molecules such as 4,5,6,7-tetrabromo-1H-benzotriazole (IC50 = 300 nM) and 4,5,6,7-tetrabromo-2-(dimethylamino)benzimidazole (IC50 = 140 nM). Modifications, including 4,5,6-tribromo-7-ethyl-1H-benzotriazole (IC50 = 160 nM), further improved activity. Changing scaffolds while retaining halogens has enabled design of new inhibitors. Flavonols, dibenzofuranones, and the indeno[1,2-b]indole scaffold are key examples. Halogenation of the reference molecule 5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-dione (4b, IC50 = 360 nM) significantly boosted potency. The study focused on introducing four halogens, yielding to the compound 1,2,3,4-tetrabromo-5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-dione (MC11), with an IC50 of 16 nM. Co-crystallography revealed how bromine atoms enhance binding, and MC11 demonstrated strong in cellulo activity, particularly against leukemic cell lines like IPC-Bcl2.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (NI 643/4-2)
- Agence Nationale de la Recherche (22-CE92-0081-01)
- Deutsche Forschungsgemeinschaft (JO 183/10-1, NI 643/11-1)
This publication has 68 references indexed in Scilit:
- Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promiseMolecular and Cellular Biochemistry, 2022
- 4,5,7‐Trisubstituted indeno[1,2‐b]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effectsFEBS Open Bio, 2021
- Design and synthesis of CK2 inhibitorsMolecular and Cellular Biochemistry, 2011
- Structure-based discovery of novel flavonol inhibitors of human protein kinase CK2Molecular and Cellular Biochemistry, 2011
- A CE‐based assay for human protein kinase CK2 activity measurement and inhibitor screeningElectrophoresis, 2010
- A structural insight into CK2 inhibitionMolecular and Cellular Biochemistry, 2008
- New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazoleMolecular and Cellular Biochemistry, 2008
- Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 InhibitorsChemBioChem, 2006
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: Primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway ‘leukemic stem cell line’Leukemia Research, 1983